BioCentury
ARTICLE | Company News

Regulus, California Institute of Technology deal

December 21, 2009 8:00 AM UTC

The institute granted Regulus exclusive, worldwide rights to IP covering methods and compositions for modulating microRNA-146 (miR-146) and microRNA-155 (miR-155). The company plans to use the IP to...